Evaluation of the Effects of Corticosteroids on Histamine Release by <i>ex Vivo</i> Cutaneous Microdialysis
- 1 Bioexigence SARL, Espace Lafayette, 8 rue Alfred de Vigny, Besan?on, France
- 2 Bioexigence SARL, Espace Lafayette, 8 rue Alfred de Vigny, Besan?on, France
- 3 Bioexigence SARL, Espace Lafayette, 8 rue Alfred de Vigny, Besan?on, France
- 4 Plastic Surgery, 9 rue Klein, Saint Vincent Clinic, Besan?on, France
- 5 Skinexigence SAS, immeuble Bioparc, 2 rue du Dr Paul Milleret, Besan?on, France
- 6 Research and Clinicl Center on the Tegument (CERT); Clinical Investigation Center (CIC BT506), Department of Dermatology, Besan?on University Hospital, Besan?on, France
- 7 Laboratory of Clinical and Toxicology Pharmacology, Jean Minjoz University Hospital, Besancon, France
- 8 University of Franche-Comté, Inserm U1098, SFR FED 4234 IBCT, Besan?on, France
Abstract
The purpose of the study was to evaluate the effects of corticosteroids on histamine release and to compare their potency with the MacKenzie classification based on their vasoconstrictor effects . Thanks to ex Vivo cutaneous microdialysis, we studied histamine-induced release over a period of time on excised abdominal skin from women. Eight corticosteroids were topically applied with occlusive dressing onto the skin, above probes, before anti-IgE injection. Histamine levels were assessed by an EIA method. In order to compare the different corticosteroids, AUC was calculated allowing an estimation of the amount of released histamine for 60 min of ex vivo cutaneous microdialysis . Diflucortolone 0.1% and micronized betamethasone dipropionate 0.05% are considered as corticosteroids with high potency in MacKenzie classification. Betamethasone dipropionate associated with propylene glycol 0.05%, belongs to a stronger class in Mackenzie classification . Our results showed that the decrease in histamine release was more important with difluocortolone than with both of these corticosteroids. Therefore there was no correlation between the vasoconstrictor potency of topical corticosteroids and their ability to inhibit histamine release.
- A. W. MacKenzie and R. B. Stoughton, “A Method for Comparing Percutaneous Absorption of Steroids,” Archives of Dermatology, Vol. 86, No. 11, 1962, pp. 608-610. doi:10.1001/archderm.1962. 01590110044005
- A. W. McKenzie, “Percutaneous Absorption of Steroids,” Archives of Dermatology, Vol. 86, No. 11, 1962, pp. 611-614. doi:10.1001/archderm.1962.01590110047006
- S. Wiedersberg, C. S. Leopold and R. H. Guy, “Bioavailability and Bioequivalence of Topical Glucocorticoids,” European Journal of Pharmaceutics and Biopharmaceutics, Vol. 68, No. 3, 2008, pp. 453-466. doi:10.1016/j.ejpb.2007.08.007
- Y. Narkar, “Bioequivalence for Topical Products—An Update,” Pharmaceutical Research, Vol. 27, No. 12, 2010, pp. 2590-2601. doi:10.1007/s11095-010-0250-3
- Organisation for Economic Co-operation and Development (OECD), “Test Guideline 427: In Vitro Method,” Paris, 2004.
- T. J. Franz, P. A. Lehman and S. G. Raney, “Use of Excised Human Skin to Assess the Bioequivalence of Topical Products,” Skin Pharmacology and Physiology, Vol. 22, No. 5, 2009, pp. 276-286. doi:10.1159/ 000235828
- A. Le Quellec, S. Dupin, P. Genissel, S. Saivin, B. Marchand and J. P. M. Houin, “Microdialysis Probes Calibration: Gradient and Tissue Dependent Changes in No Flux and Reverse Dialysis Methods,” Journal of Pharmacoogical and Toxicological Methods, Vol. 33, No. 1, 1995, pp. 11-16. doi:10.1016/1056-8719(94)00049-A
- N. Leveque, S. Makki, J. Hadgraft and P. Humbert, “Comparison of Franz Cells and Microdialysis for Assessing Salicylic Penetration through Human Skin,” International Journal of Pharmaceutics, Vol. 269, No. 2, 2004, pp. 323-328. doi:10.1016/j.ijpharm.2003.09.012
- I. Brody, “Mast Cell Degranulation in the Evolution of Acute Eruptive Guttate Psoriasis Vulgaris,” Journal of Investigative Dermatology, Vol. 82, No. 5, 1984, pp. 460464. doi:10.1111/1523-1747.ep12260955
- A. L. Krogstad, G. Lonnroth, B. F. G. Larson and B. G. Wallin, “Nerve-Induced Histamine Release Is of Little Importance in Psoriatic Skin,” British Journal of Dermatology, Vol. 139, No. 5, 1998, pp. 403-409. doi:10.1046/j.1365-2133.1998.02402.x
- T. Ishizaka, D. H. Conrad, T. F. Huff, D. D. Metcalfe, R. L. Stevens and R. A. Lewis, “Unique Features of Human Basophilic Granulocytes Developed in in Vitro Culture,” International Archives of Allergy and Applied Immunology, Vol. 77, No. 1-2, 1985, pp. 137-143. doi:10.1159/000233768